Kumari, A
Your Patient Care Coordinator and clinical team guide each step, helping you build repeatable, sustainable progress and a healthier metabolism that lasts
Results from Eli Lillys SURMOUNT-3 and SURMOUNT-4 trials are in, and they confirmed that its GLP-1 / GIP agonist tirzepatide (aka Mounjaro) drives significant weight loss among obese or overweight adults who dont have type 2 diabetes
Author contributions GB, EM, and MB performed the clinical assessment
Yes, it may help reduce dark spots and promote an even complexion, leading to a more radiant appearance
Figure 1: Changes in A) sociability index, B) social novelty index, C) # USVs evoked, D) % marbles buried, E) grooming time in seconds between control mice and mice treated with MT-II Finally, the study explored differences in oxytocin receptor expression in the brains of MIA mice compared to normal C57BL/6J mice